Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury  被引量:1

Use of ebselen as a neuroprotective agent in rat spinal cord subjected to traumatic injury

在线阅读下载全文

作  者:Wojciech ?lusarczyk Edyta Olakowska Magdalena Larysz-Brysz Izabella Woszczycka-Korczyńska Daria Gendosz de Carrillo W?adys?aw P.W?glarz Joanna Lewin-Kowalik Wies?aw Marcol 

机构地区:[1]Department of Physiology,Medical University of Silesia [2]Institute of Nuclear Physics,Polish Academy of Sciences

出  处:《Neural Regeneration Research》2019年第7期1255-1261,共7页中国神经再生研究(英文版)

摘  要:Spinal cord injury(SCI) causes disturbances of motor skills.Free radicals have been shown to be essential for the development of spinal cord trauma.Despite some progress,until now no effective pharmacological therapies against SCI have been verified.The purpose of our experiment was to investigate the neuroprotective effects of ebselen on experimental SCI.Twenty-two rats subjected to SCI were randomly subjected to SCI with no further treatment(n = 10) or intragastric administration of ebselen(10 mg/kg) immediately and 24 hours after SCI.Behavioral changes were assessed using the Basso,Beattie,and Bresnahan locomotor scale and footprint test during 12 weeks after SCI.Histopathological and immunohistochemical analyses of spinal cords and brains were performed at 12 weeks after SCI.Magnetic resonance imaging analysis of spinal cords was also performed at 12 weeks after SCI.Rats treated with ebselen presented only limited neurobehavioral progress as well as reduced spinal cord injuries compared with the control group,namely length of lesions(cysts/scars)visualized histopathologically in the spinal cord sections was less but cavity area was very similar.The same pattern was found in T2-weighted magnetic resonance images(cavities) and diffusion-weighted images(scars).The number of FluoroGold retrogradely labeled neurons in brain stem and motor cortex was several-fold higher in ebselen-treated rats than in the control group.The findings suggest that ebselen has only limited neuroprotective effects on injured spinal cord.All exprimental procedures were approved by the Local Animal Ethics Committee for Experiments on Animals in Katowice(Katowice,Poland)(approval No.19/2009).Spinal cord injury(SCI) causes disturbances of motor skills.Free radicals have been shown to be essential for the development of spinal cord trauma.Despite some progress,until now no effective pharmacological therapies against SCI have been verified.The purpose of our experiment was to investigate the neuroprotective effects of ebselen on experimental SCI.Twenty-two rats subjected to SCI were randomly subjected to SCI with no further treatment(n = 10) or intragastric administration of ebselen(10 mg/kg) immediately and 24 hours after SCI.Behavioral changes were assessed using the Basso,Beattie,and Bresnahan locomotor scale and footprint test during 12 weeks after SCI.Histopathological and immunohistochemical analyses of spinal cords and brains were performed at 12 weeks after SCI.Magnetic resonance imaging analysis of spinal cords was also performed at 12 weeks after SCI.Rats treated with ebselen presented only limited neurobehavioral progress as well as reduced spinal cord injuries compared with the control group,namely length of lesions(cysts/scars)visualized histopathologically in the spinal cord sections was less but cavity area was very similar.The same pattern was found in T2-weighted magnetic resonance images(cavities) and diffusion-weighted images(scars).The number of FluoroGold retrogradely labeled neurons in brain stem and motor cortex was several-fold higher in ebselen-treated rats than in the control group.The findings suggest that ebselen has only limited neuroprotective effects on injured spinal cord.All exprimental procedures were approved by the Local Animal Ethics Committee for Experiments on Animals in Katowice(Katowice,Poland)(approval No.19/2009).

关 键 词:EBSELEN ANTIOXIDANT NEUROPROTECTION NEUROREGENERATION SPINAL CORD injury SPINAL CORD repair functional recovery 

分 类 号:R[医药卫生]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象